1:10 PM
 | 
Dec 05, 2017
 |  BC Extra  |  Politics & Policy

J&J, Sanofi top list for clinical trial transparency

In a paper published in the British Medical Journal Open, Bioethics International found that clinical trial transparency is high among large pharmas and their newly approved drugs, with Johnson & Johnson (NYSE:JNJ) and Sanofi (Euronext:SAN; NYSE:SNY) topping the list. The group also said transparency has improved since 2012 by some measures.

The group analyzed 505 clinical trials that supported FDA approval of 19 drugs...

Read the full 303 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >